Study of Continuous APL-1202 Treatment in Subjects With High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Relapsed From Intravesical Chemo/BCG Therapy
Clinical trial NCT04498702 · COMPLETED
Trial details
- NCT number
- NCT04498702
- Sponsor
- Jiangsu Yahong Meditech Co., Ltd aka Asieris
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-13
- Primary completion
- 2017-01-18
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.